tci Part B Insider - 2004 Issue 14

CHEMOTHERAPY: One Carrier Pushes Defunct Code For Zevalin, Bexxar

Don't treat draft local coverage decisions as gospel   If you're using monoclonal antibodies Bexxar and Zevalin in a diagnostic study aimed at determining the location of a tumor or the biodistribution of the agent, you could be in for some confusion.   CPT Codes 2004 introduced a new code, 78804, for radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agents requiring more than two days' imaging. And, as of April 1, Medicare phased out the old codes G0273 and G0274, for studies and therapeutic uses involving radiopharmaceutical agents.   But at least one carrier hasn't caught up to...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.